Biotech Growth Share Discussion Threads

[affemoose] 10/1/2014 13:52

now £5!

[philo124] 19/12/2013 20:45

Coincidence, just moved into new house and finally sorted my paperwork out after 3 months in limbo. Came across BIOG paperwork to file and saw my last note-"£4!" bought for my son at £1. So pleased it's up another 10%.
As with IBT and PCT these are great to sit alongside yielders that have got no eps growth, Come to think about it, Would have been better forgetting the high yielders.

[rford78] 19/12/2013 19:15

harry - agree 50% is excellent performance but at the end of the day it's still under performing and lagging behind its peer group/benchmark. IBB the US passive biotech etf is up over 60% , and it only has an expense ratio of 0.48% vs BIOG's TER of 1.31%, 1.31% of a £50,000 investment is £655. You're paying £655 for underperformance and their Christmas bonuses and salaries. ..I'll take 60% any day.

[harry the haddock] 19/12/2013 17:13

I'm quite happy to stay - if all my picks increased 50% in a year I'd be a rich man!

[bashby] 19/12/2013 17:07

I also sold out today - same reasoning :)

[rford78] 19/12/2013 16:49

Sold some of this underperforming miscreant BIOG,after finally seeing some strength today. I'm better off shorting ATM puts instead in IBB (Nasdaq biotech etf) , a passive etf fund which has been beating BIOG (actively maaged) by nearly 10% ytd. The BIOG fund manager has been underperforming for a while and they are doing hardly anything about it, but being unjustifiably paid to collect their undeserved annual fees/TER and fat bonuses.

[rford78] 18/11/2013 14:09

Discount is greater than 7% as of today morning and has been persisting for couple days now , why won't the fund managers initiate the buyback - it's in the trust's mandate: "...In early 2005, the Company introduced a discount control mechanism, with a commitment to protect a discount of 6% through the buyback of shares, which are then cancelled. This active policy has successfully kept the discount to within acceptable limits...."

[rbdc1] 02/8/2013 19:59

MadmixIn fairness the discount been at 14% before.Think it may be approaching a buying opportunity given today's NAV in the 440's

[madmix] 01/8/2013 21:47

rbdc1,

Over the past year, this has traded in a range between a 5% discount and 4% premium.

So this could be seen as a buying opportunity.

www.trustnet.com/Webservices/Charting.asmx/GetDiscountPremiumChart?width=650&height=250&unitCode=AKR0&span=12

[rbdc1] 01/8/2013 18:10

Odd that BIOG is now 4% below its NAV when it used to trade at a slight premium...

[rford78] 26/7/2013 21:25

For an actively managed fund, BIOG seems to be lagging the major (passive) biotech etfs (ibb/fbt etc) over the past few months which is dismal given fund manager's hefty fees and annual management charges.

[protean] 17/7/2013 08:56

Prognosis: Healthy earnings for pharma, biotech

www.cnbc.com/id/100890557

[protean] 14/7/2013 10:53

The sector is on a roll:

dealbook.nytimes.com/2013/07/11/biotech-companies-surge-as-investors-flock-to-them/

[davebowler] 08/7/2013 14:11

IBT was less volatile over the last few weeks.

[philo124] 06/7/2013 08:35

Had a skip through Annual Report and accounts. Just keep holding. In fact should
have certainly added on the dip a few weeks ago.

[rogerrail] 20/5/2013 16:20

harry
switched to IBT in mid march for a 13.5% return v 9.5% for BIOG over the same period, not earth shattering, but the 11% NAV discount should close further if IMO the sector index continues to rise. This will provide a degree of leverage to the share price

[tiger20] 20/5/2013 15:47

Shares going well-as long as USA confidence keeps going-its the best performing I.Trust share over last 2/3 years

[rogerbridge] 13/5/2013 17:41

Nice tick up today.

[harry the haddock] 13/5/2013 15:36

maybe so but Biotech Growth beats it on every timescale for performance

[davebowler] 13/5/2013 15:15

IBT is still 11% below NAV.

[affemoose] 19/4/2013 08:45

Looking like it's trading at NAV now.

[harry the haddock] 08/4/2013 14:35

just bought some of these for my sipp. let's hope the recent superb returns continue. had never considered a biotech IT but the returns stood out, looked at them a bit more, the managers are a good experienced pairing and they invest in some massive companies who are market leaders in their sectors. fingers crossed...

[affemoose] 08/4/2013 11:23

Wow - that is the best response to a shareholder query I have ever had.

Hats off to frostrow - 14 minutes!!!!!!!

See below:

"The announcements that you mention relate to issues of new shares to satisfy demand in the market. New shares are issued at a premium to the prevailing net asset value per share to ensure that existing shareholders are not disadvantaged. The funds received are used to make further investments by the Investment manager."